You are viewing the site in preview mode

Skip to main content

Table 2 Mendelian randomization analysis validating causal relationships at the proteomic level

From: Identification of novel proteins in inflammatory bowel disease based on the gut-brain axis: a multi-omics integrated analysis

Exposure

Method

Beta

Se

Pval

OR(95%CI)

IBD

     

 LSP1

Wald ratio

0.44

0.10

8.30E-06

1.55(1.28,1.89)

 LNPEP

Wald ratio

-2.20

0.47

3.54E-06

0.11(0.04,0.28)

 TYK2

Wald ratio

-0.93

0.14

6.75E-11

0.39(0.29,0.52)

 GPX1

Wald ratio

-1.35

0.15

6.50E-20

0.25(0.19,0.34)

 SULT1A1

Wald ratio

-0.38

0.07

9.15E-09

0.68(0.60,0.77)

 FDPS

Wald ratio

-0.81

0.18

6.63E-06

0.44(0.31,0.63)

 GPSM1

Wald ratio

-1.48

0.47

1.56E-03

0.22(0.09,0.56)

 AUH

Wald ratio

-1.57

0.34

3.45E-06

0.20(0.10,0.40)

 INPP5E

Wald ratio

-1.84

0.26

2.11E-12

0.15(0.09,0.26)

CD

     

 FDPS

Wald ratio

-1.32

0.24

5.72E-08

0.26(0.16,0.42)

 INPP5E

Wald ratio

-2.22

0.35

3.80E-10

0.10(0.05,0.21)

 PDLIM4

Wald ratio

-0.72

0.18

4.87E-05

0.48(0.34,0.68)

 GPX1

Wald ratio

-1.38

0.20

7.14E-12

0.25(0.17,0.37)

 SULT1A1

Wald ratio

-0.50

0.09

3.37E-08

0.60(0.51,0.72)

 HINT1

Wald ratio

-2.19

0.48

6.16E-06

0.11(0.04,0.28)

UC

     

 GPX1

Wald ratio

-1.30

0.19

2.48E-12

0.27(0.19,0.39)

 LSP1

Wald ratio

0.59

0.12

8.43E-07

1.80(1.42,2.28)

 AUH

Wald ratio

-1.76

0.43

3.61E-05

0.17(0.07,0.39)

 PANK4

Wald ratio

-1.70

0.73

0.02

0.18(0.04,0.76)

 INPP5E

Wald ratio

-1.44

0.33

1.11E-05

0.23(0.12,0.45)

  1. Mendelian Randomization analysis was conducted to validate the causal relationships between IBD, CD, UC, and the brain proteins identified by PWAS